Asthma And COPD Patients Are Highly Satisfied With The Handling And Inhalation From The New Generation Soft Mist Inhaler
Tue, 12 Sep 2006 07:00 AM EST
... The results of an observational study presented today at the 16th Annual Congress of the European Respiratory Society in Munich, Germany show that patients with asthma and chronic obstructive pulmonary disease (COPD) are highly satisfied with the novel Respimat® Soft Mist Inhaler (SMI) from Boehringer Ingelheim. [click link for full article] ...
Related Topics
- Asthma
- Asthma & Allergies
- Fluticasone Inhalation Aerosol
- Epinephrine Inhalation Aerosol
- Asthma in Children
- Tiotropium bromide
- Fluticasone and Salmeterol Oral Inhalation
- Ipratropium Bromide Oral Inhalation
- Beclomethasone Oral Inhalation
- Flunisolide Oral Inhalation
- Albuterol Inhaler
- Albuterol and Ipratropium
- Soft Tissue Sarcoma
- Triamcinolone Oral Inhalation
- Cromolyn Inhaler
- Nicotine Inhaler
- Safe Blood Handling
- COPD (Chronic Obstructive Pulmonary Disease)
- Pirbuterol Acetate Oral Inhalation
- Acetylcysteine Inhalation Solution

Not Signed In -

